Skip to content

Effectiveness and safety assessment of orthopedic device for low back pain

Effectiveness and safety assessment of orthopedic device(LSM-01) for low back pain: a randomized, single-blinded, sham-controlled, parallel-group, pilot clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0006425
Enrollment
30
Registered
2021-08-05
Start date
2021-08-02
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Test device : orthopedic device(LSM-01) Control device : sham device(connection between the motor part and the roller is removed) Use in 45 degree lateral position, both gluteus mediu

Sponsors

Cheonan Korean Medicine Hospital of Daejeon University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) 19-70 year old male and female 2) Subject with lumbar pain above VAS 40mm and those who are taking analgesics for lumbar pain 3) Subject who voluntarily decides to participate in the study after hearing a sufficient explanation of the purpose of the test and the process and signs the informed consent form

Exclusion criteria

Exclusion criteria: 1) Those who have a history of vertebral fracture or spinal surgery, or have a scheduled surgery within the examination period 2) Those who have had severe back pain with a VAS of 75mm or more, lasting for 3 days or more within 3 months before participating in the trial 3) Those with neurological symptoms of sensory and motor paralysis or abnormal findings on L-spine x-ray and CT 4) Those who have pain in other parts of the body which is more severe than lower back pain 5) Those who cannot have friction due to skin diseases, inflammation, or wounds around the spine, pelvis, and hip joints 6) In case of concurrent treatment for back pain other than analgesic medication 7) Those with serious underlying diseases such as serious cardiovascular disease or tumor 8) Those with a history of alcohol or drug abuse 9) Those who cannot write measurement data for subjects by themselves or under the supervision of a guardian/researcher 10) Those who have participated in other interventional clinical trials within 30 days of trial participation 11) Any other researcher deemed inappropriate for this test

Design outcomes

Primary

MeasureTime frame
VAS(Visual Analogue Scale)

Secondary

MeasureTime frame
Pressure pain threshold (PPT);Oswestry Disability Index: ODI;PGIC(Patient Global Impression of change)

Countries

Korea, Republic of

Contacts

Public ContactGa-hyeon Jung

Cheonan Korean Medicine Hospital of Daejeon University

cherubss@naver.com+82-41-521-7579

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 13, 2026